Today: 3 June 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

KALA BIO (KALA) Stock Explodes on Oxford Deal and $10M Offering: What December 4, 2025 Means for Investors

KALA BIO (KALA) Stock Explodes on Oxford Deal and $10M Offering: What December 4, 2025 Means for Investors

KALA BIO shares jumped about 50% to $1.40 on December 4 after announcing a $10 million registered direct offering at $1.00 per share. Oxford Finance converted debt into a 16.5% equity stake, and new CEO David Lazar invested $6 million in preferred stock. Trading volume topped 100 million shares, far exceeding the company’s roughly 8.2 million share float. The moves follow a failed drug trial and cash sweep in October.
4 December 2025
·
Applied Materials (AMAT) Stock Near Record Highs as TD Cowen Sets $315 Target and Analysts Double Down on AI, DRAM and TSMC Upside

Applied Materials (AMAT) Stock Near Record Highs as TD Cowen Sets $315 Target and Analysts Double Down on AI, DRAM and TSMC Upside

Applied Materials shares hit all-time highs near $270 after TD Cowen raised its price target to $315 and named the company a “best idea” for 2026. The firm cited strong demand for AI and DRAM equipment, with new projects at Samsung, Micron, and TSMC expected to boost growth. Morgan Stanley also raised its target to $273. Some analysts warn of export risks and a cooling China market.
4 December 2025
····
Regeneron (REGN) Price Target Hits $1,057 as BMO and Canaccord Lift Forecasts on Dupixent Growth

Regeneron (REGN) Price Target Hits $1,057 as BMO and Canaccord Lift Forecasts on Dupixent Growth

BMO Capital raised its Regeneron price target to $850, citing Dupixent momentum and improved Eylea HD trends. Canaccord Genuity set a Street-high target of $1,057, expecting Dupixent growth to offset Eylea declines. Regeneron now holds a “Moderate Buy” consensus from 28 analysts, with an average target near $768. The stock has surged over 50% in six months amid active institutional trading.
4 December 2025
·
Tonix Pharmaceuticals (TNXP) Stock Today, December 4, 2025: Tonmya Launch, Buyback and $400M ATM Define a Volatile Biotech Story

Tonix Pharmaceuticals (TNXP) Stock Today, December 4, 2025: Tonmya Launch, Buyback and $400M ATM Define a Volatile Biotech Story

Tonix Pharmaceuticals’ stock (NASDAQ: TNXP) closed near $19.98 on December 4, 2025, up roughly 10–12% for the day and about 10,515% over the past year. The surge follows FDA approval and U.S. launch of Tonmya, the first new fibromyalgia drug in over 15 years. Market cap stands near $190 million. Investors remain focused on whether Tonmya sales can offset heavy cash burn and potential dilution.
4 December 2025
··
UnitedHealth Group (UNH) Stock Today: Latest News, Analyst Forecasts and 2026 Outlook as of December 4, 2025

UnitedHealth Group (UNH) Stock Today: Latest News, Analyst Forecasts and 2026 Outlook as of December 4, 2025

UnitedHealth Group shares traded around $333–340 on December 4, 2025, down over 45% from last year’s high after a year marked by a cyberattack, DOJ investigations, and the killing of a top executive. Stephen Hemsley returned as CEO amid the turmoil. Despite the rebound from lows, the stock remains about 25–30% lower year-to-date, underperforming the S&P 500.
4 December 2025
·
Archer Aviation (ACHR) Stock Today: Miami Air Taxi Network, Defense Deals and New Ratings – What December 4, 2025 Means for Investors

Archer Aviation (ACHR) Stock Today: Miami Air Taxi Network, Defense Deals and New Ratings – What December 4, 2025 Means for Investors

Archer Aviation traded around $8.40 per share on December 4, 2025, with a market cap near $6.2 billion and a 52-week range of $5.48 to $14.62. The company announced plans for a Miami air-taxi network using its Midnight eVTOL aircraft, linking major airports and city hubs. Trading volume exceeded 11 million shares by mid-morning, with short interest at 14% and institutional ownership at 51%.
4 December 2025
··
ON Semiconductor (NASDAQ: ON) Stock Outlook for December 2025: AI Power, $6 Billion Buyback and SiC Mega-Fab Fuel the Next Leg

ON Semiconductor (NASDAQ: ON) Stock Outlook for December 2025: AI Power, $6 Billion Buyback and SiC Mega-Fab Fuel the Next Leg

ON Semiconductor shares jumped 15% in the past week and now trade near $56, with a market cap of about $20.6 billion and short interest around 16%. Q3 2025 revenue reached $1.55 billion, beating estimates but down 12% year-over-year, while adjusted EPS fell to $0.63. Automotive and industrial segments grew sequentially. Management forecasts Q4 revenue between $1.48 billion and $1.58 billion.
4 December 2025
···
BlackRock (BLK) Stock on 4 December 2025: New Income ETF, Infrastructure Pivot and AI-Driven 2026 Outlook

BlackRock (BLK) Stock on 4 December 2025: New Income ETF, Infrastructure Pivot and AI-Driven 2026 Outlook

BlackRock shares traded near $1,080 on December 4, 2025, valuing the firm at about $176 billion. The company launched the iShares Nasdaq Premium Income Active ETF this week and paused plans for a European infrastructure fund. Analysts’ 12-month price targets suggest mid-teens to low-20s percentage upside from current levels. The stock offers a $20.84 annual dividend, with the next ex-dividend date set for December 5.
4 December 2025
···
Kroger (KR) Stock on December 4, 2025: Q3 Earnings, Guidance Shift and Mixed Forecasts Explained

Kroger (KR) Stock on December 4, 2025: Q3 Earnings, Guidance Shift and Mixed Forecasts Explained

Kroger shares fell about 6% to near $62 on December 4 after reporting a $1.54 billion Q3 operating loss, driven by a $2.6 billion impairment on its automated fulfillment network. Adjusted EPS rose to $1.05, slightly beating estimates, while total sales reached $33.9 billion. The stock is down 14% from its 52-week high but remains up 4–5% year-to-date.
4 December 2025
··
Surf Air Mobility (SRFM) Stock Today: Price, Palantir Partnership, Q3 Results and 2026 Forecasts – 4 December 2025

Surf Air Mobility (SRFM) Stock Today: Price, Palantir Partnership, Q3 Results and 2026 Forecasts – 4 December 2025

Surf Air Mobility shares rose 8% to $2.49 intraday on December 4 after Q3 revenue beat guidance at $29.2 million and the company raised its outlook. The stock remains down 44% year-to-date and faces a going-concern warning and dilution risk. Q3 net loss widened to $27.2 million, while adjusted EBITDA loss was $9.9 million. Trading volume reached 1.7 million shares.
4 December 2025
··
MrBeast Financial, Beast Mobile and a Fan-Focused IPO: How Jimmy Donaldson Is Turning His YouTube Empire Into a Fintech Powerhouse

MrBeast Financial, Beast Mobile and a Fan-Focused IPO: How Jimmy Donaldson Is Turning His YouTube Empire Into a Fintech Powerhouse

Beast Industries CEO Jeffrey Housenbold announced at the DealBook Summit on Dec. 3, 2025, that the company will launch MrBeast Financial, a fintech platform, and Beast Mobile, a branded wireless service. Both target MrBeast’s massive online audience. Housenbold also said an IPO is under consideration. Beast Industries generated over $400 million in revenue last year but remains unprofitable.
4 December 2025
·
Bristol Myers Squibb (BMY) Stock Today: Cobenfy Trial Twist, AI Drug Discovery Milestone and $6.7 Billion Lawsuit Shape the 2026 Outlook

Bristol Myers Squibb (BMY) Stock Today: Cobenfy Trial Twist, AI Drug Discovery Milestone and $6.7 Billion Lawsuit Shape the 2026 Outlook

Bristol Myers Squibb shares rallied this week, trading near $50.55 after news on its Alzheimer’s drug Cobenfy, an AI drug discovery milestone, and a key lawsuit ruling. The company declared a $0.62 quarterly dividend, bringing the annual yield to about 4.9%. Market cap stands at $104 billion. Despite the rebound, BMY shares remain down roughly 15% for 2025.
4 December 2025
··
GameStop Corp. WT (GME.WS / GME‑WT) Warrants in Focus: Price Today, December 2025 Outlook and Key Risks

GameStop Corp. WT (GME.WS / GME‑WT) Warrants in Focus: Price Today, December 2025 Outlook and Key Risks

GameStop’s GME.WS warrants surged over 13% in 24 hours, closing at $4.22 on December 4, 2025, with after-hours quotes at $4.26. Issued as a dividend in October, the warrants let holders buy GME shares at $32 until October 2026. Trading volume reached up to 700,000 shares. The move comes ahead of GameStop’s earnings and a “Trade Anything Day” event.
4 December 2025
·
CIBC Stock Today (CM): Q4 2025 Earnings Beat, Dividend Hike and 2026 Outlook

CIBC Stock Today (CM): Q4 2025 Earnings Beat, Dividend Hike and 2026 Outlook

CIBC reported Q4 2025 revenue of C$7.58 billion, up 14% year-over-year, and net income of C$2.18 billion, up 16%. Adjusted earnings per share reached C$2.21, beating analyst estimates. Shares traded near 52-week highs on both TSX and NYSE, with U.S. shares up about 37% year-to-date. The bank raised its dividend and announced leadership changes for 2026.
4 December 2025
···
Bank of Montreal (BMO) Stock: Q4 2025 Earnings Beat, Dividend Hike and What It Means for 2026

Bank of Montreal (BMO) Stock: Q4 2025 Earnings Beat, Dividend Hike and What It Means for 2026

Bank of Montreal reported fiscal 2025 net income of C$8.73 billion, up 19% year-over-year, and raised its dividend. Shares traded near multi-year highs, closing at C$177.02 on the TSX and $126.76 USD on the NYSE. Adjusted Q4 net income rose 63% to C$2.51 billion, with credit losses down sharply. The stock’s year-to-date gain outpaced the S&P 500.
4 December 2025
···
1 … 536 537 538 539 540 … 587

Stock Market Today

  • BlackLine (BL) Valuation Analysis Underlines Mixed Signals After Recent Price Moves
    June 3, 2026, 5:32 PM EDT. BlackLine (BL) closed at $30.48 after a 3% drop, marking a 6% weekly gain but a 10% monthly decline in a volatile period. The stock is down 43% year-to-date, with a 47% decline in shareholder returns. Analysts place its fair value at $32, suggesting slight undervaluation amid cautious sentiment. BlackLine trades at a high price-to-earnings (P/E) ratio of 67.2x versus 64.2x for peers and 29.3x for the U.S. Software sector, highlighting valuation risks. Market watchers debate if the current price factors in future growth or risks, including AI product impact and share buybacks. Investors are advised to monitor earnings multiples and industry dynamics for clearer pricing signals.

Latest articles

Mirion Gains While Wall Street Slides—What’s Behind MIR’s Move

Mirion Gains While Wall Street Slides—What’s Behind MIR’s Move

3 June 2026
Mirion jumped 1.1% to $18.24 on strong volume while major indexes fell, as investors focused on its nuclear-safety business after a University of Liverpool partnership and robust Q1 revenue and orders, despite a GAAP net loss and lowered adjusted EPS guidance due to a CEO retention grant.
CrowdStrike Tops Forecasts but Shares Drop as AI Expenses Gain Attention

CrowdStrike Tops Forecasts but Shares Drop as AI Expenses Gain Attention

3 June 2026
CrowdStrike shares plunged about 8% after hours as investors overlooked strong revenue and raised guidance to focus on rising AI and product development costs, with first-quarter operating expenses jumping to $1.07 billion from $934.3 million a year earlier, despite a four-for-one stock split and record cash flow.
POET Stock Jumps Again as AI-Optics Trade Heats Up, Legal Risk Lingers

POET Stock Jumps Again as AI-Optics Trade Heats Up, Legal Risk Lingers

3 June 2026
POET Technologies shares soared 12% to $15.47 after heavy trading, rebounding from April’s collapse tied to a canceled Marvell-linked order, as investors weighed a new $50 million Lumilens deal, a $400 million capital raise, and ongoing class action litigation alleging misleading statements about tax status and confidentiality breaches.
Meta Jumps After Zuckerberg Puts AI Agent at Center of $145 Billion Gamble

Meta Jumps After Zuckerberg Puts AI Agent at Center of $145 Billion Gamble

3 June 2026
Meta shares jumped 4.2% to $622.80 after unveiling an AI business agent for WhatsApp, Messenger, and Instagram, signaling potential new paid products as Meta ramps up AI spending to $125–$145 billion for 2026; investors await evidence these tools can generate real revenue before costs climb further.
Go toTop